LFST vs. PINC, PRVA, USPH, DNLI, NEOG, ARWR, TNDM, IMCR, TGTX, and ENOV
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Premier (PINC), Privia Health Group (PRVA), U.S. Physical Therapy (USPH), Denali Therapeutics (DNLI), Neogen (NEOG), Arrowhead Pharmaceuticals (ARWR), Tandem Diabetes Care (TNDM), Immunocore (IMCR), TG Therapeutics (TGTX), and Enovis (ENOV). These companies are all part of the "medical" sector.
Premier (NASDAQ:PINC) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, community ranking, institutional ownership and valuation.
Premier has a net margin of 6.01% compared to Premier's net margin of -15.69%. LifeStance Health Group's return on equity of 11.71% beat Premier's return on equity.
Premier currently has a consensus price target of $23.50, indicating a potential upside of 18.81%. LifeStance Health Group has a consensus price target of $8.80, indicating a potential upside of 19.40%. Given Premier's stronger consensus rating and higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than Premier.
74.4% of Premier shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 0.9% of Premier shares are owned by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Premier has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks.
In the previous week, Premier and Premier both had 11 articles in the media. Premier's average media sentiment score of 0.32 beat LifeStance Health Group's score of 0.24 indicating that LifeStance Health Group is being referred to more favorably in the news media.
Premier received 602 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 69.07% of users gave Premier an outperform vote while only 26.32% of users gave LifeStance Health Group an outperform vote.
Premier has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.
Summary
Premier beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
